Alpha-1-Antitrypsin Deficiency Liver Disease

Clin Liver Dis. 2018 Nov;22(4):643-655. doi: 10.1016/j.cld.2018.06.010. Epub 2018 Aug 22.

Abstract

In homozygous ZZ alpha-1-antitrypsin (AAT) deficiency, the liver synthesizes large quantities of AAT mutant Z, which folds improperly during biogenesis and is retained within the hepatocytes and directed into intracellular proteolysis pathways. These intracellular polymers trigger an injury cascade, which can lead to liver injury. This is highly variable and not all patients develop liver disease. Although not fully described, there is likely a strong influence of genetic and environmental modifiers of the injury cascade and of the fibrotic response. With improved understanding of liver injury mechanisms, new strategies for treatment are now being explored.

Keywords: Alpha 1 antitrypsin; Autophagy; ERAD; Protein polymer; Proteolysis; siRNA.

Publication types

  • Review

MeSH terms

  • Alleles
  • Apoptosis / genetics
  • Cell Proliferation / genetics
  • Genotype*
  • Hepatocytes
  • Humans
  • alpha 1-Antitrypsin / genetics*
  • alpha 1-Antitrypsin / metabolism
  • alpha 1-Antitrypsin Deficiency / diagnosis*
  • alpha 1-Antitrypsin Deficiency / genetics*
  • alpha 1-Antitrypsin Deficiency / therapy

Substances

  • alpha 1-Antitrypsin